Advancement into the Arctic Region for Bioactive Sponge Secondary Metabolites
AbstractPorifera have long been a reservoir for the discovery of bioactive compounds and drug discovery. Most research in the area has focused on sponges from tropical and temperate waters, but more recently the focus has shifted to the less accessible colder waters of the Antarctic and, to a lesser extent, the Arctic. The Antarctic region in particular has been a more popular location for natural products discovery and has provided promising candidates for drug development. This article reviews groups of bioactive compounds that have been isolated and reported from the southern reaches of the Arctic Circle, surveys the known sponge diversity present in the Arctic waters, and details a recent sponge collection by our group in the Aleutian Islands, Alaska. The collection has yielded previously undescribed sponge species along with primary activity against opportunistic infectious diseases, malaria, and HCV. The discovery of new sponge species and bioactive crude extracts gives optimism for the isolation of new bioactive compounds from a relatively unexplored source. View Full-Text
- Supplementary File 1:
PDF-Document (PDF, 341 KB)
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Abbas, S.; Kelly, M.; Bowling, J.; Sims, J.; Waters, A.; Hamann, M. Advancement into the Arctic Region for Bioactive Sponge Secondary Metabolites. Mar. Drugs 2011, 9, 2423-2437.
Abbas S, Kelly M, Bowling J, Sims J, Waters A, Hamann M. Advancement into the Arctic Region for Bioactive Sponge Secondary Metabolites. Marine Drugs. 2011; 9(11):2423-2437.Chicago/Turabian Style
Abbas, Samuel; Kelly, Michelle; Bowling, John; Sims, James; Waters, Amanda; Hamann, Mark. 2011. "Advancement into the Arctic Region for Bioactive Sponge Secondary Metabolites." Mar. Drugs 9, no. 11: 2423-2437.